Cancer

Testicular Cancer Research

Cancer » Testicular Cancer » Testicular Cancer Research

Testicular cancer research is a reliable method to try out different combinations to curb or eliminate malignant growth in the testicular areas and prevent its recurrence. Primary aim of the research on testicular cancer is to monitor cell abnormality in varying conditions and come out with the best possible method to tackle them effectively and in minimum possible time. Testicular cancer breakthrough helps to explore new techniques to make the detection and treatment of the disease more transparent and reliable.

What is testicular cancer research?

Testicular cancer is a kind of malignant growth in the testicular areas and the tumors may also spread to the abdominal areas, prostate, penis or lungs. The tumors can be of various types and shapes depending upon the stage in which the cancer has progressed. Benign or the non-cancerous tumors formed in or near the testicles are usually undamaging to the testicular health and do not kill tissues or cells present in the areas. They are easy to tackle by surgery and usually do not redevelop.

Testicular cancer is more common in Caucasian race and occurs less frequently in black people. Also, the numbers of cases are more common in Europe and America as compared to Africa and Asia. The disease targets primarily the young people aged between 20-40 years and is less common in people below 20 years. The risk of generation of cancerous tumors in the testicles increases with age and may also occur in people beyond 40 years of age if they have family history of the disease.

Causes of the testicular cancer may vary from person to person and also depend upon the age of the victim. Some of the causes can be hereditary or genetic and may pose a threat to an individual in the later stages of life. Also, the symptoms or early signs for the disease are not the same in all victims. Some may show symptoms much different and much subtle as compared to the regular or universally known symptoms of the disease. This is because the health and immune system is different for different persons. Some may suffer from various non-cancerous disorders or malfunctioning of some of the vital parts of the body and may have the greater risk of being infected by malignant growth.

All such variations may influence cancerous generation in the testicles to a great extent and make a person highly susceptible to cancer attack. Research on testicular cancer plays an important role in analyzing the prime causes and symptoms of the disease so that the malignant growth can be controlled right in the early stages. It also helps to replace the old methods and techniques by the latest ones and make the diagnosis and treatment process more accurate and timely. Research also focuses on recommending the best post-treatment care pattern so that the mental and physical recovery of the person is fast and safe.

What is testicular cancer breakthrough?

Breakthrough for testicular cancer focuses on the latest and relevant happenings in the field of testicular cancer and makes people aware of the output of the ongoing research. Breakthroughs can be related to the detection, nature, diagnosis, cure pattern or post-treatment care for testicular cancer and may help to know the disease better. Breakthrough can also be about the risk factors and early signs related to the disease and help to identify the tumors cells early.

Thus, breakthrough deals with new findings and suggestions in the field of testicular cancer. Many research organizations related to testicular cancer studies carry out consistent research to explore reliable and effective breakthroughs that can be applied universally or at least to a considerably large number of patients. Effectiveness of breakthroughs may change with times and are closely related to the changing habits and lifestyle pattern of the people.

Latest in testicular cancer research and testicular cancer breakthrough

Chemotherapy has come up as a better option as compared to the radiation treatment to treat cancerous growth in the testicles as the prior has less side-effects in comparison to the later. Testicular cancer research is in progress to study the changing pattern of DNA of the abnormal cells generated during testicular cancer. Men who are infected by AIDS (Acquired Immune Deficiency Syndrome) have higher risk of being prone to the disease as compared to those who are not HIV-positive. According to research conducted by Rigshospitalet University of Denmark, over-exposure to environmental endocrine disrupting chemicals (EDCs) that are usually found in pesticides, paints, plasticizers or fatty foods may increase the risk of testicular cancer.

Consumption of a drug called marijuana has been found to be a major cause of the disease and may even result into the death of the patient. Taller men are found to have the risk of testicular cancer as high as 13% as compared to the normal-heighted people. High or improper dosage of chemotherapy is found to create obstacles in detecting early signs for recurrent testicular cancer. Following stem cell transplant after chemotherapy to replace the damaged cells by new and healthy ones have been found to be effective to reduce the side-effects of the treatment and avoid recurrence of malignant growth.

Testicular cancer research is beneficial for both patients as well as the oncologists. Testicular cancer breakthroughs can be very helpful in making people aware of the disorder well in advance and changing patterns of the cancer. It may also help in making the most out of the current treatment patterns and help in implementing the necessary changes in the personal habits and lifestyle pattern of men who are at a higher risk of being targeted by the cancer cells in the testicles.

Cancer Articles!